# US 7,745,117 B2 · Methods for incorporating non-perfectly matched oligonucleotides into target-specific hybridization sequences > Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt - Number: US 7,745,117 B2 - Document ID: US7745117B2 - Status: Granted - Kind: B2 - Application number: 10/862,662 - Filed: 2004-06-07 - Published: 2005-03-24 - Granted: 2010-06-29 - Earliest claimed: 2003-06-06 - Assignees: The Regents of the University of Michigan - Inventors: Inhan Lee - Web page: https://patentgrep.com/patent/US7745117B2 ## CPC - C12Q 1/6813: Hybridisation assays - C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES ## Abstract The present invention provides a method of designing target-specific hybridization sequences which include one or more mutations. The method of the invention comprises selecting a candidate target nucleotide sequence in a subject nucleotide sequence. A first complementary nucleotide sequence to the target nucleotide sequence is identified by applying the known bonding relationships of the nucleotides. Next, a second complementary nucleotide sequence having one or more mutations is constructed. The amount of the “target-second complementary nucleotide sequence” hybrid formed when the candidate target nucleotide sequence and second complementary nucleotide sequences are combined in the presence of interfering sequences is characterized and used to assess utility of the second complementary nucleotide sequence. The present invention also provides the target-specific hybridization sequences designed by the methods of the invention. ## Claims ### Claim 1 A method of making a hybridization probe the method comprising: receiving a target-specific hybridization sequence identified by: a) selecting a candidate target nucleotide sequence in a subject nucleotide sequence; b) identifying one or more interfering nucleotide sequences, wherein the interfering nucleotide sequences have at least a predetermined number of sequential nucleotides in common with the candidate target nucleotide sequence; c) identifying a first complementary nucleotide sequence to the target nucleotide sequence; d) determining a set of replacement positions Pn in the first complementary nucleotide sequence by locating each position at which a G is located; e) creating a set of second complementary nucleotide sequences by replacing each G at the replacement position with a nucleotide selected from the group consisting of T/U, C, and A, wherein each member of the set of second complementary nucleotide sequences has a single G replaced; f) characterizing the amount of “target-second complementary nucleotide sequence” hybrid formed when the target and second complementary nucleotide sequences are combined in the presence of potentially interfering sequences; g) identifying the second complementary nucleotide sequence as a symbolic representation of a target-specific hybridization sequence if the amount of “target-second complementary nucleotide sequence” hybrid is greater than a predetermined value; h) determining a set of replacement positions Pn in the first complementary nucleotide sequence by locating each position at which a C or A or T/U if the first complementary nucleotide sequence did not have a G or the amount of “target-second complementary nucleotide sequence” hybrid was not greater than the predetermined value; i) creating the set of second complementary nucleotide sequences by replacing C or A or T/U identified in step h) at the replacement position with a non-complementary nucleotide; j) characterizing the amount of “target-second complementary nucleotide sequence” hybrid formed when the target and second complementary nucleotide sequences are combined in the presence of potentially interfering sequences; and k) identifying the second complementary nucleotide sequence as the symbolic representation of a target specific hybridization sequence if the amount of “target-second complementary nucleotide sequence” hybrid is greater than a predetermined value, and generating an actual nucleotide sequence that is incorporated in the hybridization probe. ### Claim 2 (depends on 1) The method of claim 1 wherein the subject nucleotide sequence has a length equal to or greater than the candidate target nucleotide sequence. ### Claim 3 (depends on 1) The method of claim 1 wherein the candidate target nucleotide sequence and the second complementary nucleotide sequence are not self complementary. ### Claim 4 (depends on 1) The method of claim 1 wherein the step of selecting the candidate target nucleotide sequence comprises: selecting an initial starting position from an end in the subject nucleotide sequence; identifying a set of candidate target sequences beginning at a set of starting positions given by the formula Xo+nA that include a predetermined number of nucleotides, wherein Xo is the initial starting position, n is an integer greater than or equal to 0 and is limited so that no sequence extends past the end of the test sequence, and A is an offset number of nucleotides between adjacent members in the set of candidate sequences; quantifying the amount of interfering sequences for each member in the set of candidate target sequences; and arranging the set of candidate target sequences from a sequence with the least amount of interfering sequences to a sequence with the greatest amount of interfering sequences. ### Claim 5 (depends on 4) The method of claim 4 wherein steps a through k are recursively executed with a different selected member from the set of candidate target sequences until a predetermined number of target-specific hybridization sequences are identified, the selected member first being sequentially selected from the member of the set with the least amount of interfering sequences to the member with the greatest amount of interfering sequences. ### Claim 6 (depends on 5) The method of claim 5 wherein A is from 1 to 50 nucleotides in length, and each member in the set of candidate sequences has from about 15 to about 100 nucleotides. ### Claim 7 (depends on 6) The method of claim 6 wherein Xo is at a position from the first position to about the 1500th position in the subject nucleotide sequence. ### Claim 8 (depends on 1) The method of claim 1 wherein the target nucleotide sequence is selected by: choosing a sequence from the collection of nucleotide sequences; identifying a nucleotide at a predetermined position from an end of the sequence; and selecting as the candidate target nucleotide sequence a nucleotide sequence starting at the predetermined position that includes a predetermined number of nucleotides. ### Claim 9 (depends on 1) The method of claim 1 further comprising: determining a replacement position in the first complementary nucleotide sequence at which a C is located, wherein a predetermined number of nucleotides from each end of the subject nucleotide sequence are excluded from consideration when determining the replacement position; and creating the second complementary nucleotide sequences by replacing the C at the replacement position with a nucleotide selected from the group consisting of T/U, G, and A. ### Claim 10 (depends on 1) The method of claim 1 further comprising: determining a replacement position in the first complementary nucleotide sequence at which an A is located, wherein a predetermined number of nucleotides from each end of the subject nucleotide sequence are excluded from consideration when determining the replacement position; and creating the second complementary nucleotide sequences by replacing the A at the replacement position with a nucleotide selected from the group consisting of T/U and C. ### Claim 11 (depends on 1) The method of claim 1 further comprising: determining a replacement position in the first complementary nucleotide sequence at which a T/U is located, wherein a predetermined number of nucleotides from each end of the subject nucleotide sequence are excluded from consideration when determining the replacement position; and creating the second complementary nucleotide sequences by replacing the T/U at the replacement position with a nucleotide selected from the group consisting of A and C. ### Claim 12 (depends on 1) The method of claim 1 further comprising: prior to step f, identifying one or more interfering nucleotide sequences, wherein the interfering nucleotide sequences have at least a predetermined number of sequential nucleotides in common with the second complementary nucleotide sequence. ### Claim 13 (depends on 12) The method of claim 12 wherein the interfering nucleotide sequences have at least 14 sequential nucleotides in common with the target complementary nucleotide sequence. ### Claim 14 (depends on 12) The method of claim 12 wherein the step of characterizing the amount of the “target-second complementary nucleotide sequence” hybrid comprises: calculating the differences between a hybridization function for a “target-second complementary nucleotide sequence” hybrid and an “interfering sequences-second complementary nucleotide sequence” hybrid, the hybridization function providing quantification of the amount of hybridization; and step g comprises: if the differences are such that the amount of the “target-second complementary nucleotide sequence” hybrid is greater than the predetermined value, identifying the second complementary nucleotide sequence as the target-specific hybridization sequence. ### Claim 15 (depends on 14) The method of claim 14 wherein the hybridization function is the melt temperature, the difference in Gibbs free energy, interaction energy, or the percent hybridization. ### Claim 16 (depends on 1) The method of claim 1 further comprising: l) if the first complementary nucleotide sequence did not have a G or the differences were not greater than the predetermined value, determining a set of replacement positions Pn in the first complementary nucleotide sequence by locating each position at which a C is located; m) creating the set of second complementary nucleotide sequences by replacing each C at the replacement position with a nucleotide selected from the group consisting of T/U, G, and A, wherein each member of the set of second complementary nucleotide sequences has a single C replaced; n) characterizing the amount of “target-second complementary nucleotide sequence” hybrid formed when the target and second complementary nucleotide sequences are combined in the presence of potentially interfering sequences; and o) if the amount of “target-second complementary nucleotide sequence” hybrid is greater than a predetermined value, identifying the second complementary nucleotide sequence as the symbolic representation of a target specific hybridization sequence. ### Claim 17 (depends on 16) The method of claim 16 further comprising: p) if the first complementary nucleotide sequence did not have a C or the differences were not greater than the predetermined value, determining a set of replacement positions Pn in the first complementary nucleotide sequence by locating each position at which a A or T/U is located; q) creating the set of second complementary nucleotide sequences by replacing each A at the replacement position with a nucleotide selected from the group consisting of T/U and C or by replacing each T/U at the replacement position with a nucleotide selected from the group consisting of A and C, wherein each member of the set of second complementary nucleotide sequences has a single C replaced, r) characterizing the amount of “target-second complementary nucleotide sequence” hybrid formed when the target and second complementary nucleotide sequences are combined in the presence of potentially interfering sequences; and s) if the amount of “target-second complementary nucleotide sequence” hybrid is greater than a predetermined value, identifying the second complementary nucleotide sequence as the symbolic representation of a target specific hybridization sequence. ### Claim 18 (depends on 1) The method of claim 1 wherein steps a-g are implemented on a microprocessor. ### Claim 19 (depends on 1) The method of claim 1 wherein the mismatch is at a position exclusive of a predetermined number of nucleotides at either end of the second complementary nucleotide sequence.